Menu Back to 10th-DIA-China-Annual-Meeting

概览

转眼瞬间已九载,凝神常思向十年。2018年,DIA中国年会将迎来10周岁。

十年前,当中国尚未全面参与国际多中心临床试验时,DIA来到中国,在北京主办召开了以“从‘平坦世界’的视角看药物研发:创新、法规和全球化”为主题的第一届中国年会。自2009年首届年会以来,DIA在中国的十年,是见证中国医药风雨兼程地从传统制药走向自主创新的十年,是中国医药健康产业蓬勃发展的十年,也是见证中国药监改革快速发展硕果累累的十年。刚刚过去的两年中,国家食品药品监督管理局(CFDA)已经展示了前所未有的决心,推出了一系列措施深化制度改革,确保公众用药的有效性与安全性。

2017年5月21日,在上海国际会议中心举办的第九届DIA中国年会上,CFDA--DIA联合举办的有关ICH的研讨会向世界传递了来自中国的坚定的声音。2017年6月,CFDA正式加入ICH标志了中国药监历史上的一个重要的里程碑。

2018年,第十届DIA中国年会,DIA亚洲最大的跨学科盛会,您是否想参加?您是否想在中国生命科学创新如此激动人心的时刻为非凡事件贡献一份力量?



第十届 DIA 中国年会设有壁报展览。这是一个交流知识和经验,应用新技术和新方法的良机。

精选主题

  • 开幕特别论坛
  • 监管科学
  • CFDA专场
  • 创新性突破治疗(肿瘤、心血管疾病等)
  • 临床开发(运营、基地、GCP等)
  • 定量科学
  • CMC及仿制药
  • 生物制品及生物类似物开发
  • 医学事务
  • 药物安全与药物警戒
  • 患者参与
  • 医疗健康的大数据研究与人工智能
  • 医疗器械、伴随诊断、IVD
  • 热点话题(罕见病、心血管领域多方合作、投资与商务拓展、Portfolio管理、支付方等)

项目委员会

  • Pei  HU
    Pei HU Director, Phase I Unit, Clinical Pharmacological Research Center
    Peking Union Medical College, China
  • Bin  Xue
    Bin Xue Director-General
    China Center for Food and Drug International Exchange, CFDA, China
  • Wendy  Yan, MD, MBA
    Wendy Yan, MD, MBA Senior Vice President, Head of Regulatory Affairs
    BeiGene (Beijing) Co., Ltd., China
  • Irene  Deng
    Irene Deng Vice President, Head of China Regulatory Affairs
    AstraZeneca, China
  • Jin  Cui
    Jin Cui Program Officer
    China Center for Food and Drug International Exchange , China
  • George  LIU
    George LIU Head of Early Development and Scientific Operation
    Harbour Biomed, China
  • Zhiqiang  Ning
    Zhiqiang Ning Vice President, Research & Clinical Development
    Shenzhen Chipscreen Biosciences, Ltd., China
  • Jessica  Liu
    Jessica Liu Vice President, Head of International Business
    TigerMed China, China
  • Sunny  Zhu
    Sunny Zhu Chief Medical Officer, Infectious Diseases
    Everest Medicines, China
  • Hannah  Chen, MD
    Hannah Chen, MD Director, Asia Pacific Strategy Lead
    BioResearch Quality & Compliance, Janssen, China
  • Paul  Dai, MD
    Paul Dai, MD Head of Clinical Operations
    TDC, Asia, Takeda, China
  • Reako  Ren
    Reako Ren Head of SMO Services
    WuXi Apptec., China
  • Connie  DAI
    Connie DAI
    Harbour Biomed, China
  • Hualong  Sun
    Hualong Sun General manager
    Meta Clinical Technical Co. Ltd, China
  • Charles  Yan
    Charles Yan Vice President
    Hengrui Data Science Center, China
  • Melly  Lin
    Melly Lin Senior Regulatory Manager, CMC Policy,
    Roche(China) Holding Ltd, China
  • Joe  Zhang
    Joe Zhang Former Head of Preclinical R&D
    Simcere Pharmaceutical Group, China
  • Xiangyang  Zhu
    Xiangyang Zhu CEO
    Shanghai Huaota Biopharma Co., Ltd, China
  • Li L Wang
    Li L Wang Vice President, Medical
    Eli Lilly, China
  • Xiaoling  Wang
    Xiaoling Wang Clinical Documentation
    Clinical Science Operation, Sanofi R&D China, China
  • Xue  TANG
    Xue TANG Drug Safety Unit Regional Head (DRH),
    APAC Pfizer, China
  • Dayao  ZHAO, MD, PhD
    Dayao ZHAO, MD, PhD Vice President and Lead, China Drug Development
    Pfizer, China
  • Jane Y. Cai, PhD
    Jane Y. Cai, PhD Former Managing Director
    DIA China, China
  • Tony  Guo
    Tony Guo Executive Director, Head of Biometrics China
    BeiGene, China
  • Tong  Guo
    Tong Guo Vice President and Head of Sales
    Greater China IQVIA, China
  • Amber  Wang
    Amber Wang Vice President, Regulatory Affairs & QA
    SmithNephew, China
  • Ruyi  He, MD
    Ruyi He, MD Chief Scientist
    Center for Drug Evaluation, CFDA, United States
  • Jingsong  WANG, MD
    Jingsong WANG, MD CEO
    Harbour Biomed (HBM), China
  • Shun  Lu
    Shun Lu Director, Shanghai Lung Cancer Center
    Shanghai Jiaotong University, China
  • Xianglin  Zhang
    Xianglin Zhang President
    Shenyang Pharmaceutical University, China
  • Carol  Zhu, MBA
    Carol Zhu, MBA Senior Vice President and Managing Director
    DIA China, China
  • Ron D. Fitzmartin, DIAFellow, PhD, MBA
    Ron D. Fitzmartin, DIAFellow, PhD, MBA Senior Advisor, Office of Strategic Programs, CDER
    FDA, United States
  • Murray M. Lumpkin, DIAFellow, MD, MSc
    Murray M. Lumpkin, DIAFellow, MD, MSc Deputy Director, Regulatory Affairs, Lead Global Regulatory Systems Initiatives
    Bill and Melinda Gates Foundation, United States
  • Kenneth A. Getz, DIAFellow, MBA
    Kenneth A. Getz, DIAFellow, MBA Director of Sponsored Research Programs and Associate Professor
    Center For the Study of Drug Development, Tufts University School of Medicine, United States
  • Sandra A. Milligan, DIAFellow, JD, MD
    Sandra A. Milligan, DIAFellow, JD, MD Senior Vice President, Head of Global Regulatory Affairs and Clinical Safety
    Merck Research Laboratories, United States
  • Ling  Su, DIAFellow, PhD
    Ling Su, DIAFellow, PhD Past President, DIA Board of Directors; Professor
    Shenyang Pharmaceutical University, China
Load More